Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

3

Number of overlapping holdings

7.3%

% of IBRN's 55 holdings also in LFSC

9.7%

% of LFSC's 31 holdings also in IBRN

Overlap by Weight
Sector Drift (IBRN minus LFSC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in IBRN
Weight
in LFSC
Overlap
INTRA-CELLULAR THERAPIES INC 4.6% 6.0% 4.6%
SAREPTA THERAPEUTICS INC 3.9% 4.1% 3.9%
ACADIA PHARMACEUTICALS INC 4.4% 2.2% 2.2%

Position Highlights (Non-Overlapping Exposures)
IBRN Overweight Relative to LFSC
PTC THERAPEUTICS INC 6.0%
SCHOLAR ROCK HOLDING CORP. 5.5%
ALKERMES PLC 4.6%
ARGENX SE ADR 4.5%
CATALYST PHARMACEUTICAL PART 4.4%
NEUROCRINE BIOSCIENCES INC 4.3%
SK BIOPHARMACEUTICALS CO., LTD. 3.8%
SUPERNUS PHARMACEUTICALS INC 3.8%
EDGEWISE THERAPEUTICS, INC. 3.2%
DYNE THERAPEUTICS INC 3.2%
IBRN Underweight Relative to LFSC
RADNET INC -8.8%
INSMED INC -6.0%
WAVE LIFE SCIENCES LTD. -6.0%
LIVANOVA PLC -5.9%
BLUEPRINT MEDICINES CORP. -5.7%
MERIT MEDICAL SYSTEMS INC -5.3%
NEOGENOMICS INC -4.9%
SOLENO THERAPEUTICS INC -4.4%
BRIDGEBIO PHARMA, INC. -4.3%
COLLEGIUM PHARMACEUTICAL, INC. -4.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY